Evidence map›Paper›PMID 28861673›Full record

ArticleNeurochemical research2018

SOD1 Mutations Causing Familial Amyotrophic Lateral Sclerosis Induce Toxicity in Astrocytes: Evidence for Bystander Effects in a Continuum of Astrogliosis.

Nicole Wallis, Chew L Lau, Manal A Farg, Julie D Atkin, Philip M Beart, Ross D O'Shea

Abstract read
PubMed Publisher
In one paragraph

Article in Neurochemical research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. The Role of GM130 in Nervous System Diseases.Frontiers in neurology · 2021
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Golgi Structure and Function in Health, Stress, and Diseases.Results and problems in cell differentiation · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Nicole WallisNeurodegeneration, Florey Institute of Neuroscience and Mental Health, Parkville, Australia.
Chew L LauNeurodegeneration, Florey Institute of Neuroscience and Mental Health, Parkville, Australia.
Manal A FargNeurodegeneration, Florey Institute of Neuroscience and Mental Health, Parkville, Australia.
Julie D AtkinNeurodegeneration, Florey Institute of Neuroscience and Mental Health, Parkville, Australia.
Philip M BeartNeurodegeneration, Florey Institute of Neuroscience and Mental Health, Parkville, Australia. philip.beart@florey.edu.au.
Ross D O'SheaDepartment of Physiology, Anatomy and Microbiology, La Trobe University, Bundoora, Australia.
Florey Institute of Neuroscience and Mental Health · AULa Trobe University · AU

Funding

Bethlehem Griffiths Research Foundation Postgraduate scholarshipNational Health and Medical Research Council 454749National Health and Medical Research Council 509319National Health and Medical Research Council Fellowship
6 · The paper itself

Abstract

Astrocytes contribute to the death of motor neurons via non-cell autonomous mechanisms of injury in amyotrophic lateral sclerosis (ALS). Since mutations in the gene encoding Cu/Zn superoxide dismutase (SOD1) underlie the neuropathology of some forms of familial ALS, we explored how expression of mutant SOD1 protein A4V SOD1-EGFP affected the biology of secondary murine astrocytes. A4V SOD1-EGFP expressing astrocytes (72 h after transfection) displayed decreased mitochondrial activity (~45%) and L-glutamate transport (~25%), relative to cells expressing wild-type SOD1-EGFP. A4V SOD1-EGFP altered F-actin and Hoechst staining, indicative of cytoskeletal and nuclear changes, and altered GM130 labelling suggesting fragmentation of Golgi apparatus. SOD1 inclusion formation shifted from discrete to "punctate" over 72 h with A4V SOD1-EGFP more rapidly producing inclusions than G85R SOD1-EGFP, and forming more punctate aggregates. A4V, not wild-type SOD1-EGFP, exerted a substantial, time-dependent effect on GFAP expression, and ~60% of astrocytes became stellate and hypertrophic at 72 h. Spreading toxicity was inferred since at 72 h ~80% of bystander cells exhibited hypertrophy and stellation. This evidence favours mutant SOD1-containing astrocytes releasing destructive species that alter the biology of adjacent astrocytes. This panoply of mutant SOD1-induced destructive events favours recruitment of astrocytes to non-cell autonomous injury in ALS.

Indexed as

Amyotrophic Lateral SclerosisAnimalsAstrocytesMice, Inbred C57BLMitochondriaMotor NeuronsSuperoxide DismutaseSuperoxide Dismutase-1Sod1 protein, mouseSuperoxide DismutaseSuperoxide Dismutase-1BystanderGFAPInclusionStellationSuperoxide dismutase

Identifiers

PMID28861673
OpenAlexW2753338351

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.